tiprankstipranks
Trending News
More News >
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
US Market

Corvus Pharmaceuticals (CRVS) Income Statement

Compare
643 Followers

Corvus Pharmaceuticals Income Statement

Last quarter (Q3 2025), Corvus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Corvus Pharmaceuticals's net income was $-10.16M. See Corvus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -632.00K
Operating Expenses
$ 27.55M$ 23.41M$ 32.56M$ 38.63M$ 43.76M
Depreciation and Amortization
$ 85.00K$ 151.00K$ 367.00K$ 460.00K$ 632.00K
EBITDA
$ -27.46M$ -23.26M$ -32.20M$ -38.17M$ -5.36M
Operating Income
$ -27.55M$ -23.41M$ -32.56M$ -38.63M$ -43.76M
Other Income/Expenses
$ -34.74M$ -3.62M$ -8.74M$ -4.61M$ 37.77M
Pretax Income
$ -62.29M$ -27.03M$ -41.31M$ -43.24M$ -6.00M
Net Income
$ -62.29M$ -27.03M$ -41.31M$ -43.24M$ -6.00M
Per Share Metrics
Basic EPS
$ -1.02$ -0.56$ -0.89$ -1.03$ -0.20
Diluted EPS
$ -1.02$ -0.56$ -0.89$ -1.03$ -0.20
Weighted Average Shares Outstanding
60.99M 48.03M 46.55M 41.85M 29.48M
Weighted Average Shares Outstanding (Diluted)
60.99M 48.03M 46.55M 41.85M 29.48M
Currency in USD

Corvus Pharmaceuticals Earnings and Revenue History